Xu Wang

9PUBLICATIONS
2CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 28, 2026
KDM6A promotes diabetic retinopathy via H3K27me3-dependent ferroptosis in Müller cells.

|Nov 18, 2025
Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma.

Xin Chen, Xin Hu, Jun Chen

|Nov 03, 2025
KDM6A phosphorylation suppresses PER2 to confer a glycolytic vulnerability in HNSCC.

Jun Chen, Yikang Ji, Xin Chen

|Feb 05, 2025
Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU.

Xin Hu, Yikang Ji, Mi Zhang

|Jul 26, 2021
Restoration of H3k27me3 Modification Epigenetically Silences Cry1 Expression and Sensitizes Leptin Signaling to Reduce Obesity-Related Properties.

Yan Wei, Jun Chen, Xing Xu

|May 14, 2021
Targeting epigenetic modulation of cholesterol synthesis as a therapeutic strategy for head and neck squamous cell carcinoma.

Xing Xu, Jun Chen, Yan Li

Pageof 2

Frequent Collaborators

1 joint publications

Xin Chen

1 joint publications

Yan Wei